Characterizing Treatment Patterns and Healthcare Use in Patients and Subgroups with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Real-World Study.

Neurol Ther · 2026 · PMC12804543 · PMID 41313584

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The immunoglobulin plus corticosteroid combination showed a trend of providing the longest treatment duration at 10 months among patients with refractory CIDP in LOT1.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.